A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 21 Apr 2018
At a glance
- Drugs Etanercept (Primary) ; Disease-modifying antirheumatics
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors TSH Biopharm
- 11 Apr 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 26 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 26 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.